Affluent Medical SA (EPA:CVX)

Market Cap	110.57M +111.3%
Revenue (ttm)	5.27M +306.6%
Net Income	-14.74M
EPS	-0.38
Shares Out	39.35M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	62,685
Average Volume	45,199
Open	2.760
Previous Close	2.810
Day's Range	2.660 - 2.940
52-Week Range	1.160 - 2.950
Beta	0.79
RSI	84.76
Earnings Date	Apr 24, 2026

About Affluent Medical

Affluent Medical SA, a medical technology company, develops and markets minimally invasive minimally invasive medical devices in the field of urology and structural heart in France. It offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardiozis technology for treating abdominal aortic aneurysm. The company was founded in 2011 and is headquartered in Aix-en-Provence, France.

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2011
• Employees: 76
• Stock Exchange: Euronext Paris
• Ticker Symbol: CVX

Financial Performance

In 2024, Affluent Medical's revenue was 5.35 million, an increase of 337.09% compared to the previous year's 1.22 million. Losses were -14.74 million, -5.84% less than in 2023.